Nov 11, 2021 / 07:40PM GMT
Adam Evan Heussner - Crédit Suisse AG - Research Division - Research Analyst
All right. We can go ahead and get started. Hello, everyone. I'm Adam Heussner, part of the technology -- part of the health care technology and distribution team here at Credit Suisse. Thanks, everyone, for joining us.
Next up, we have Peter Kuipers, Executive VP and CFO; and Kathleen Nemeth, VP of IR from Omnicell. A way of background, Omnicell is a leading provider of solutions targeting patient safety and operational efficiency in health care facilities. Peter joined Omnicell in 2015 as Executive VP and CFO.
Peter is going to begin with a quick presentation, and then we can open the line for Q&A. But with that, Peter, over to you.
Peter J. Kuipers - Omnicell, Inc. - Executive VP & CFO
Yes. Thank you, Adam. I thought what we would do is we'll give an overview of the company's strategy, our platform offering and our go-to-market approach and momentum that we have. This is a presentation that's available publicly on our website as
Omnicell Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot